@prefix orcid: . @prefix this: . @prefix sub: . @prefix np: . @prefix dct: . @prefix pav: . @prefix rdf: . @prefix npx: . @prefix xsd: . @prefix rdfs: . @prefix biolink: . @prefix prov: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { a biolink:ChemicalEntity; rdfs:label "milnacipran" . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "Fibromyalgia" . sub:_1 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a rdf:Statement . } sub:provenance { sub:assertion prov:generatedAtTime "2022-06-24T12:01:11+00:00"^^xsd:integer; prov:hadPrimarySource ; prov:wasAttributedTo orcid:0000-0002-1501-1082; prov:wasQuotedFrom "Milnacipran HCl tablets are indicated for the management of fibromyalgia." . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB"; npx:hasSignature "CDUyd/M5aMIqRxTdagWPoSdi+Kg3Pgpd1sV1aLdlxFbbGHtyQ3IJomlPFd4oJHvjiMOXqPlXzTNpoK/pQio2zX9cHFalR50LbHDjQG6bZ8Wp2s+/3BFrGEfiG3u6ywTplK6WOzUX2KwNB1PtWzN0h7/LhqaWSpCrf5HODdazhpI="; npx:hasSignatureTarget this: . this: dct:created "2022-06-24T12:01:11+00:00"^^xsd:integer; pav:createdBy orcid:0000-0002-1501-1082; a npx:ExampleNanopub . }